Where biomanufacturing reality meets commercial execution.
Sweetgrass Bio partners with advanced therapies organizations to align manufacturing, quality, and regulatory realities with commercial strategy and execution. Consulting services are grounded in deep, hands-on experience across the biologics and plasmid DNA value chains.
“Sweetgrass thrives in challenging environments. It is resilient, purposeful, and deeply rooted. That’s the model for how we work.” Christy Franco, PhD · Founder, Sweetgrass Bio
Your commercial partner with manufacturing depth and scientific fluency.
“Most consultants understand the strategy or the science. I’ve lived inside both, from the bioreactor to the term sheet.”
Founded in 2025, Sweetgrass Bio is led by Dr. Christy Franco, a commercial operations leader with more than 15 years of experience guiding biotech and CDMO organizations through growth and transformation. With a Ph.D. in Bioengineering from Rice University and deep domain expertise across the plasmid DNA value chain, Dr. Franco spent over a decade driving commercial functions for a world-leading plasmid DNA CDMO, building commercial infrastructure, establishing go-to-market strategy, and managing full life-cycle GMP manufacturing campaigns before founding Sweetgrass Bio.
Under this direction, Sweetgrass works with advanced therapy developers, CDMOs, and platform technology companies navigating the critical gap between scientific readiness and commercial execution. Operational depth is paired with strategic clarity that only comes from having built these systems from the inside.
One integrated view across three practice areas.
Sweetgrass Bio works alongside your team to expand your market reach and build commercial systems that will hold on their own.
You have the science. I’ll build the business development infrastructure to identify and get in front of the right people.
- Fractional business development
- BD Pipeline design & qualification
- Partnering strategy & term sheet support
- MKT positioning & competitive landscape
- Conference & campaign planning
Your manufacturing capability is an asset. I’ll help you articulate it and align your development timelines and capacity commitments with customer needs.
- CDMO capability gap assessments
- Quality system commercial readiness
- Capabilities messaging development
- Tech transfer partnership approach
- Commercial-operational KPI alignment
You’re ready to scale. I’ll evaluate and refine the systems, processes, and playbooks to support your team as it grows.
- Go-to-market strategy for new platforms
- Pricing & contracting frameworks
- Proposal & RFP response systems
- CRM implementation & refinement
- Commercial team onboarding & training
Organizations we work alongside.
Connect in Person.
Sweetgrass Bio participates in key advanced therapies conferences throughout the year. Reach out ahead of an event to schedule a one-on-one meeting.
Premier exhibition and conference dedicated to accelerating breakthroughs across the advanced therapy industry.
Representing Richter BioLogics at Booth #2628. Schedule via BIO One-on-One Partnering or connect at the booth.
Premier BD and dealmaking event in the advanced therapies space.
Annual partnering and networking event for advanced therapy executives.
Let's talk about what you're building.
Whether you're evaluating a CDMO partnership, planning a commercial launch, or trying to close the gap between your manufacturing readiness and your BD pipeline, we'd like to hear about it.
